loadpatents
Patent applications and USPTO patent grants for McCauley; Dilara.The latest application filed is for "nuclear transport modulators and uses thereof".
Patent | Date |
---|---|
Nuclear Transport Modulators And Uses Thereof App 20220177445 - Baloglu; Erkan ;   et al. | 2022-06-09 |
Nuclear transport modulators and uses thereof Grant 11,318,120 - Sandanayaka , et al. May 3, 2 | 2022-05-03 |
Hydrazide Containing Nuclear Transport Modulators And Uses Thereof App 20220073478 - Sandanayaka; Vincent P. ;   et al. | 2022-03-10 |
Nuclear Transport Modulators And Uses Thereof App 20220056038 - Sandanayaka; Vincent P. ;   et al. | 2022-02-24 |
Substituted Benzofuranyl And Benzoxazolyl Compounds And Uses Thereof App 20210403459 - Baloglu; Erkan ;   et al. | 2021-12-30 |
Aptamer Therapeutics Useful In The Treatment Of Complement-related Disorders App 20210332361 - Benedict; Claude ;   et al. | 2021-10-28 |
Nuclear transport modulators and uses thereof Grant 11,124,493 - Baloglu , et al. September 21, 2 | 2021-09-21 |
Hydrazide containing nuclear transport modulators and uses thereof Grant 11,034,660 - Sandanayaka , et al. June 15, 2 | 2021-06-15 |
Substituted benzofuranyl and benzoxazolyl compounds and uses thereof Grant 11,008,309 - Baloglu , et al. May 18, 2 | 2021-05-18 |
Aptamer therapeutics useful in the treatment of complement-related disorders Grant 10,947,544 - Benedict , et al. March 16, 2 | 2021-03-16 |
Nuclear transport modulators and uses thereof Grant 10,925,859 - Sandanayaka , et al. February 23, 2 | 2021-02-23 |
Hydrazide Containing Nuclear Transport Modulators And Uses Thereof App 20200339521 - Sandanayaka; Vincent P. ;   et al. | 2020-10-29 |
Nuclear transport modulators and uses thereof Grant 10,722,497 - Sandanayaka , et al. | 2020-07-28 |
Nuclear Transport Modulators And Uses Thereof App 20200230110 - Sandanayaka; Vincent P. ;   et al. | 2020-07-23 |
Nuclear Transport Modulators And Uses Thereof App 20200199099 - Baloglu; Erkan ;   et al. | 2020-06-25 |
Nuclear transport modulators and uses thereof Grant 10,617,677 - Sandanayaka , et al. | 2020-04-14 |
Substituted Benzofuranyl And Benzoxazolyl Compounds And Uses Thereof App 20200102292 - Baloglu; Erkan ;   et al. | 2020-04-02 |
Nuclear Transport Modulators And Uses Thereof App 20200087313 - Sandanayaka; Vincent P. ;   et al. | 2020-03-19 |
Nuclear Transport Modulators And Uses Thereof App 20200038373 - Sandanayaka; Vincent ;   et al. | 2020-02-06 |
Hydrazide containing nuclear transport modulators and uses thereof Grant 10,544,108 - Sandanayaka , et al. Ja | 2020-01-28 |
Hydrazide Containing Nuclear Transport Modulators And Uses Thereof App 20190330164 - Sandanayaka; Vincent P. ;   et al. | 2019-10-31 |
Nuclear transport modulators and uses thereof Grant 10,407,405 - Baloglu , et al. Sept | 2019-09-10 |
Substituted benzofuranyl and benzoxazolyl compounds and uses thereof Grant 10,399,963 - Baloglu , et al. Sep | 2019-09-03 |
Nuclear transport modulators and uses thereof Grant 10,335,393 - Sandanayaka , et al. | 2019-07-02 |
Aptamer Therapeutics Useful In The Treatment Of Complement-related Disorders App 20190185858 - BENEDICT; CLAUDE ;   et al. | 2019-06-20 |
Methods of promoting wound healing using CRM1 inhibitors Grant 10,202,366 - Rashal , et al. Feb | 2019-02-12 |
Nuclear Transport Modulators And Uses Thereof App 20190008833 - Sandanayaka; Vincent P. ;   et al. | 2019-01-10 |
Hydrazide containing nuclear transport modulators and uses thereof Grant 10,173,987 - Sandanayaka , et al. J | 2019-01-08 |
Substituted Benzofuranyl And Benzoxazolyl Compounds And Uses Thereof App 20180319779 - Baloglu; Erkan ;   et al. | 2018-11-08 |
Nuclear Transport Modulators And Uses Thereof App 20180289675 - Sandanayaka; Vincent ;   et al. | 2018-10-11 |
Nuclear transport modulators and uses thereof Grant 10,058,535 - Sandanayaka , et al. August 28, 2 | 2018-08-28 |
Multicyclic compounds and methods of using same Grant 9,994,558 - Baloglu , et al. June 12, 2 | 2018-06-12 |
Nuclear Transport Modulators And Uses Thereof App 20180155317 - Baloglu; Erkan ;   et al. | 2018-06-07 |
Hydrazide Containing Nuclear Transport Modulators And Uses Thereof App 20180127384 - Sandanayaka; Vincent P. ;   et al. | 2018-05-10 |
Substituted 2,3-dihydrobenzofuranyl compounds and uses thereof Grant 9,938,258 - Baloglu , et al. April 10, 2 | 2018-04-10 |
Aptamer Therapeutics Useful In The Treatment Of Complement-related Disorders App 20180030446 - BENEDICT; Claude ;   et al. | 2018-02-01 |
Nuclear transport modulators and uses thereof Grant 9,861,614 - Sandanayaka , et al. January 9, 2 | 2018-01-09 |
Substituted benzofuranyl and benzoxazolyl compounds and uses thereof Grant 9,856,241 - Baloglu , et al. January 2, 2 | 2018-01-02 |
Nuclear Transport Modulators And Uses Thereof App 20170319551 - Sandanayaka; Vincent P. ;   et al. | 2017-11-09 |
Nuclear transport modulators and uses thereof Grant 9,738,624 - Baloglu , et al. August 22, 2 | 2017-08-22 |
Hydrazide containing nuclear transport modulators and uses thereof Grant 9,714,226 - Sandanayaka , et al. July 25, 2 | 2017-07-25 |
Nuclear Transport Modulators And Uses Thereof App 20170137430 - Sandanayaka; Vincent P. ;   et al. | 2017-05-18 |
Aptamer therapeutics useful in the treatment of complement-related disorders Grant 9,617,546 - Benedict , et al. April 11, 2 | 2017-04-11 |
Multicyclic Compounds And Methods Of Using Same App 20170096417 - Baloglu; Erkan ;   et al. | 2017-04-06 |
Nuclear transport modulators and uses thereof Grant 9,585,874 - Sandanayaka , et al. March 7, 2 | 2017-03-07 |
Substituted Benzofuranyl And Benzoxazolyl Compounds And Uses Thereof App 20160368904 - Baloglu; Erkan ;   et al. | 2016-12-22 |
Nuclear Transport Modulators and Uses Thereof App 20160354347 - Sandanayaka; Vincent P. ;   et al. | 2016-12-08 |
Hydrazide Containing Nuclear Transport Modulators and Uses Thereof App 20160304472 - Sandanayaka; Vincent P. ;   et al. | 2016-10-20 |
Methods of Promoting Wound Healing Using CRM1 Inhibitors App 20160304500 - Rashal; Tami ;   et al. | 2016-10-20 |
Nuclear transport modulators and uses thereof Grant 9,428,490 - Sandanayaka , et al. August 30, 2 | 2016-08-30 |
Substituted 2,3-Dihydrobenzofuranyl Compounds And Uses Thereof App 20160221994 - Baloglu; Erkan ;   et al. | 2016-08-04 |
Nuclear Transport Modulators and Uses Thereof App 20160152596 - Baloglu; Erkan ;   et al. | 2016-06-02 |
Nuclear Transport Modulators And Uses Thereof App 20160145246 - Sandanayaka; Vincent ;   et al. | 2016-05-26 |
Adenosine Analogs And Their Use App 20160129036 - BEN-ZEEV; EFRAT ;   et al. | 2016-05-12 |
Olefin containing nuclear transport modulators and uses thereof Grant 9,303,000 - Sandanayaka , et al. April 5, 2 | 2016-04-05 |
Stabilized Aptamers to Platelet Derived Growth Factor and Their Use as Oncology Therapeutics App 20160053266 - McCauley; Dilara ;   et al. | 2016-02-25 |
Nuclear transport modulators and uses thereof Grant 9,266,843 - Sandanayaka , et al. February 23, 2 | 2016-02-23 |
Adenosine analogs and their use Grant 9,255,121 - Ben-Zeev , et al. February 9, 2 | 2016-02-09 |
Hydrazide containing nuclear transport modulators and uses thereof Grant 9,206,158 - Sandanayaka , et al. December 8, 2 | 2015-12-08 |
Hydrazide Containing Nuclear Transport Modulators And Uses Thereof App 20150274698 - Sandanayaka; Vincent P. ;   et al. | 2015-10-01 |
Nuclear transport modulators and uses thereof Grant 9,096,543 - Sandanayaka , et al. August 4, 2 | 2015-08-04 |
Hydrazide containing nuclear transport modulators and uses thereof Grant 9,079,865 - Sandanayaka , et al. July 14, 2 | 2015-07-14 |
Aptamer Therapeutics Useful in the Treatment of Complement-Related Disorders App 20150159158 - Benedict; Claude ;   et al. | 2015-06-11 |
Stabilized Aptamers To Platelet Derived Growth Factor And Their Use As Oncology Therapeutics App 20150140120 - McCauley; Dilara ;   et al. | 2015-05-21 |
Nuclear Transport Modulators and Uses Thereof App 20150111893 - Sandanayaka; Vincent P. ;   et al. | 2015-04-23 |
Hydrazide containing nuclear transport modulators and uses thereof Grant 8,999,996 - Sandanayaka , et al. April 7, 2 | 2015-04-07 |
Aptamer therapeutics useful in the treatment of complement-related disorders Grant 8,946,184 - Benedict , et al. February 3, 2 | 2015-02-03 |
Nuclear Transport Modulators and Uses Thereof App 20150018332 - Sandanayaka; Vincent P. ;   et al. | 2015-01-15 |
Hydrazide Containing Nuclear Transport Modulators And Uses Thereof App 20140364408 - Sandanayaka; Vincent P. ;   et al. | 2014-12-11 |
Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics Grant 8,853,376 - McCauley , et al. October 7, 2 | 2014-10-07 |
Hydrazide Containing Nuclear Transport Modulators And Uses Thereof App 20140235653 - Sandanayaka; Vincent P. ;   et al. | 2014-08-21 |
Adenosine Analogs And Their Use App 20140038912 - Ben-Zeev; Efrat ;   et al. | 2014-02-06 |
Nuclear Transport Modulators And Uses Thereof App 20130317031 - Sandanayaka; Vincent ;   et al. | 2013-11-28 |
Adenosine analogs and their use Grant 8,569,259 - Ben-Zeev , et al. October 29, 2 | 2013-10-29 |
Aptamer Therapeutics Useful In The Treatment Of Complement-related Disorders App 20130237589 - BENEDICT; Claude ;   et al. | 2013-09-12 |
Aptamer therapeutics useful in the treatment of complement-related disorders Grant 8,436,164 - Benedict , et al. May 7, 2 | 2013-05-07 |
Aptamer Therapeutics Useful In The Treatment Of Complement-related Disorders App 20120322860 - BENEDICT; CLAUDE ;   et al. | 2012-12-20 |
Olefin Containing Nuclear Transport Modulators And Uses Thereof App 20120258986 - Sandanayaka; Vincent P. ;   et al. | 2012-10-11 |
Aptamer therapeutics useful in the treatment of complement-related disorders Grant 8,236,773 - Benedict , et al. August 7, 2 | 2012-08-07 |
Adenosine Analogs and Their Use App 20110237529 - Ben-Zeev; Efrat ;   et al. | 2011-09-29 |
S1P Receptor Modulating Compounds and Use Thereof App 20110212940 - Burli; Roland ;   et al. | 2011-09-01 |
S1P receptor modulating compounds and use thereof Grant 7,919,519 - Burli , et al. April 5, 2 | 2011-04-05 |
S1P Receptor Modulating Compounds and Use Thereof App 20110059945 - Saha; Ashis K. ;   et al. | 2011-03-10 |
S1P receptor modulating compounds and use thereof Grant 7,855,193 - Saha , et al. December 21, 2 | 2010-12-21 |
Dihydronaphthyridinyl And Related Compounds For Use In Treating Ophthalmological Disorders App 20100286136 - Jones; Simon ;   et al. | 2010-11-11 |
Carboxamide Compounds And Their Use App 20100210633 - Lin; Jian ;   et al. | 2010-08-19 |
Benzothiadiazine Compounds And Their Use App 20100184749 - Fichman; Merav ;   et al. | 2010-07-22 |
Aptamer therapeutics useful in the treatment of complement-related disorders Grant 7,579,456 - Benedict , et al. August 25, 2 | 2009-08-25 |
Stabilized Aptamers to Platelet Derived Growth Factor and their Use as Oncology Therapeutics App 20090053138 - Preiss; Jeffrey R. ;   et al. | 2009-02-26 |
S1P receptor modulating compounds and use thereof App 20080064677 - Saha; Ashis K. ;   et al. | 2008-03-13 |
S1P receptor modulating compounds and use thereof App 20080027036 - Burli; Roland ;   et al. | 2008-01-31 |
S1P receptor modulating compounds and use thereof App 20070173487 - Saha; Ashis K. ;   et al. | 2007-07-26 |
Aptamer therapeutics useful in the treatment of complement-related disorders App 20070048248 - Benedict; Claude ;   et al. | 2007-03-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.